Actively Recruiting

Phase 2
Age: 18Years - 80Years
All Genders
Healthy Volunteers
NCT07534033

Phase II Clinical Study of Probiotic LR607 in Patients With Non-Small Cell Lung Cancer

Led by Zhujiang Hospital · Updated on 2026-04-16

46

Participants Needed

1

Research Sites

106 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this clinical trial is to understand whether Lactobacillus rhamnosus LR607 can enhance neoadjuvant chemoimmunotherapy for adult patients with non-small cell lung cancer. It will also evaluate the safety of LR607. The main questions it aims to answer include: Can LR607 improve the major pathological response of neoadjuvant chemoimmunotherapy? What is the relationship between LR607 combined with neoadjuvant chemoimmunotherapy and treatment-related adverse reactions? What changes occur in the gut microbiota composition at the species level and gut metabolites of subjects after LR607 treatment? Participants will: Take LR607 daily for 3 months Visit the hospital for check-ups and examinations every month Record their pathological response, tumor recurrence, and treatment-related adverse reactions

CONDITIONS

Official Title

Phase II Clinical Study of Probiotic LR607 in Patients With Non-Small Cell Lung Cancer

Who Can Participate

Age: 18Years - 80Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Histologically confirmed newly diagnosed patients
  • ECOG performance status 0-1
  • Age 18 years or older
  • Measurable lesions according to RECIST v1.1
  • Organ function suitable for chemotherapy and immunotherapy
Not Eligible

You will not qualify if you...

  • Active autoimmune diseases
  • Recent use of immunosuppressants
  • Interstitial lung disease
  • Other malignancies
  • History of immunotherapy
  • Active infection
  • Pregnancy or drug allergies

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Zhu Jiang Hospital of Southern Medical University

Guangzhou, China

Actively Recruiting

Loading map...

Research Team

X

Xin Li

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here